...

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P3.02a-027 A Retrospective Analysis of the Efficacy and Safety of ALK Inhibitors in ALK-Positive Lung Cancer Patients

【24h】

P3.02a-027 A Retrospective Analysis of the Efficacy and Safety of ALK Inhibitors in ALK-Positive Lung Cancer Patients

机译：p3.02a-027回顾性分析ALK阳性肺癌患者alk抑制剂的疗效和安全性分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
作者
Kazutoshi Komiya; Tomomi Nakamura; Yuki Kurihara; Haruki Hirakawa; Hironori Sadamatsu; Chiho Nakashima; Hitomi Umeguchi; Yuji Takeda; Shinya Kimura; Naoko Sueoka-Aragane;
展开▼
作者单位

Saga University;

Internal Medicine Saga University;

Saga University;

Saga University;

Japanese Red Cross Karatsu Hospital;

Saga University;

Japanese Red Cross Karatsu Hospital;

Saga University;

Saga University;

Saga University;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P3.02a-027 A Retrospective Analysis of the Efficacy and Safety of ALK Inhibitors in ALK-Positive Lung Cancer Patients [J] . Kazutoshi Komiya, Tomomi Nakamura, Yuki Kurihara, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：p3.02a-027回顾性分析ALK阳性肺癌患者alk抑制剂的疗效和安全性分析
2. P1.03-010 Efficacy and Safety of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors in ALK-Positive Non-Small Cell Lung Cancer [J] . R. Imase, S. Endo, Y. Sasahara, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P1.03-010 ALAK阳性非小细胞肺癌中的促进淋巴瘤激酶（ALK）酪氨酸激酶抑制剂的疗效和安全性
3. Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer [J] . David M. Waterhouse, Janet L. Espirito, Marc D. Chioda, Drugs - Real World Outcomes . 2020,第4期

机译：ALK阳性非小细胞肺癌患者ALK抑制剂治疗测序和结果的回顾性观察研究
4. Analysis on the Efficacy and Safety of the Patients with Advanced Ovarian Cancer [C] . Yunxia Xue, Xingyun Sun, Peijing Shi International Forum on Bioinformatics and Medical Engineering . 2015

机译：晚期卵巢癌患者的疗效和安全性分析
5. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
6. Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer [O] . David M. Waterhouse, Janet L. Espirito, Marc D. Chioda, 2020

机译：ALK阳性非小细胞肺癌患者ALK抑制剂治疗测序和结果的回顾性观察研究
7. P3.02a-027 A Retrospective Analysis of the Efficacy and Safety of ALK Inhibitors in ALK-Positive Lung Cancer Patients [O] . Kazutoshi Komiya, Tomomi Nakamura, Yuki Kurihara, 2017

机译：p3.02a-027回顾性分析ALK阳性肺癌患者alk抑制剂的疗效和安全性分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号